Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - University

University

Pierre-Guillaume Méon

ULB
" The project aims at assessing the impact of holding municipal elections in France on the spread of the covid-19 epidemic by studying the relationship between turnout and the spread of the disease in areas at different stages of the epidemic. "
Funding: We have applied for a grant from FNRS.
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
Comment: The project is at the data collection stage. No results are available yet.

Pierre-Hugues Stefanuto, PhD

ULiège 
" My main research interest is the development of complete analytical solutions for biomedical applications. I mostly focus on breath and other volatile matrices characterization. "
Publication References: Zanella, D., HENKET, M., SCHLEICH, F., Louis, R., Focant, J.-F., & Stefanuto, P.-H. (2019). Multi-matrices screening for untargeted volatilomics by GC×GC-TOFMS. European Respiratory Journal. Supplement, 54, 4272. Purcaro, G.* , Stefanuto, P.-H.* , Flavio, F., Marco, B., Wieland-Alter, W., Wright, P., & Hill, J. (2018, March). SPME-GC×GC-TOF MS fingerprint of virally-infected cell culture: Sample preparation optimization and data processing evaluation. Analytica Chimica Acta. SCHLEICH, F., Zanella, D., Stefanuto, P.-H., Dallinga, J., HENKET, M., Wouters, E. F. M., Van Steen, K., Van Schooten, F., Focant, J.-F., & Louis, R. (2019). Exhaled Volatile Organic Compounds Are Able to Discriminate Between Neutrophilic and Eosinophilic Asthma. AMERICAN JOURNAL OF...

Roberto Lazzaroni, Professor

UMONS 
" The high-performance computing facility of UMONS (Dragon 2, which is part of the Consortium des Equipements de Calcul Intensif), has been adapted and used to run the analysis of the COVID-19 phylogenetic clusters performed by the Spatial Epidemiology Laboratory at ULB (Dr. S. Dellicour and Prof. M. Gilbert). "
Contact: people involved at UMONS: Sébastien Kozlowskyj, system manager This email address is being protected from spambots. You need JavaScript enabled to view it. Prof. Roberto Lazzaroni This email address is being protected from spambots. You need JavaScript enabled to view it.

Saïd Mahmoudi, Professor - Thierry Dutoit, Full Professor - Sidi Ahmed Mahmoudi, Professor- Xavier Lessage, Eng - Sohaib Laraba, Eng - Omar Seddati, Phd - Mohammed Amin Belarbi, Eng - Olivier Debauche, Eng

UMONS - Faculty of Engineering - ILIA and ISIA Departments
" This study allows an early Covid-19 diagnosis by using AI and explainable based classification and detection methods applied to CT and X-ray datasets. Many datasets form several hospitals in Belgium are used. The goal of the project is to use AI based methods to identify Covid-19 patients. Explainable AI methods are used to provide efficient interpretation and visualization tools for the classification and detection results obtained. The second goal of this project is to create a benchmark dataset composed of chest CT and X-ray database related to Covid-19 disease. To this aim, a semi-automatic annotation tool is developed in order to allow fast image annotation by radiologists. - Explainable artificial intelligence applied to Covid-19 detection based on CT and X-ray images. - Annotation tool development to build a benchmark database. "
Funding: University of Mons - Faculty of Engineering
Publication References: ...

Serge Goldman, Scientific Director

CMMI
" The Center of Microscopy and Molecular Imaging (CMMI) is currently involved in establishing an accurate SARS-CoV-2 virus distribution topography in the organs and various cells of patients who died in COVID-19 units by providing immunohistochemistry and electron microscopy services (study director Pr. Isabelle Salmon). We have also developed and are currently offering preclinical multimodal quantitative imaging - of lung inflammation - of bacterial population (pathogen or no pathogen) - and of viral infection by isotopic imaging. All these models enable the understanding of pulmonary pathological features caused by SARS-viruses such as CoVID-19. From molecular to humanized animal models, the CMMI provides customized imaging solutions to research projects on Coronavirus The CMMI is also a proud partner of the ULB diagnostic platform set-up in Gosselies to face the epidemic of SARS-CoV2. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.
Comment: The CMMI was co-founded by ULB et UMons and is supported...

Serge Habraken, Professor

ULiège
" The Centre Spatial de Liege is developing a process for mask recycling by cleaning, decontamination and dehydradation. The process combines ethanol/water mix cleaning with an innovative outgassing step under vacuum. The decontamination is already proven thanks to the collaboration with the Veterinary Faculty . The outgassing step aims to retrieve mask performance (mainly filtration efficiency) close to original. "
Funding: No, internal ULiege project
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Simon Dellicour, FNRS Postdoctoral Researcher

ULB - FNRS
" Since the start of the COVID-19 pandemic, an unprecedented number of genomic sequences of the causative virus (SARS-CoV-2) have been publicly released. The resulting volume of available genetic data presents a unique opportunity to gain real-time insights into the pandemic, but also a daunting computational hurdle if analysed with gold-standard phylogeographic methods. We here describe and apply an analytical pipeline that is a compromise between fast and rigorous analytical steps. As a proof of concept, we focus on Belgium, one of the countries with the highest spatial density of sequenced SARS-CoV-2 genomes. At the global scale, our analyses confirm the importance of external introduction events in establishing transmission chains in the country. At the country scale, our spatially-explicit phylogeographic analyses highlight an impact of the national lockdown of mid-March on both the long-distance dispersal events and the dispersal velocity of viral lineages. Our...

Sofia Morra, FNRS Research Fellow

ULB, Hôpital Erasme - FNRS
Lung injury, endothelial dysfunction and the role of RAAS during SARS-CoV-2 invection. " The first case of a person infected with SARS-Cov-2 virus can be tracked back on November the 17th, 2019, in China. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 outbreak a pandemic. On April 13, COVID-19 is affecting 210 countries and territories worldwide, about 2 million positive cases have been officially declared along with 115.000 deaths. The real number of infected and deaths is scarily higher, considering that up to 65% people are asymptomatic and thus, not tested. The percentage of patients with COVID-19 needed for intensive care unit (ICU) varied from 5 to 32% in Wuhan, China. It was up to 9% in Lombardy, Italy. According to available data from Lombardy, 99% of patients admitted to the ICU needed respiratory support (88% invasive ventilation, 11% non invasive ventilation). In this unprecedented time, while SARS-Cov-2 virus is halting...

Sophie Vanwambeke, Professor - Catherine Linard, Professor - Marius Gilbert, FNRS Senior Research Associate - Simon Dellicour, FNRS Postdoctoral Researcher

ULB, UCLouvain, UNamur - FNRS
" Since early March, we have monitored spatial features of the epidemic, and various possible spatial determinants of its progression, including demographic, socio-economic and environmental indicators. We are also investigating the predictive and explanatory value of various indicators of mobility. Since the beginning of the covid-19 pandemic in Belgium, we observed strong spatial patterns in the disease case incidence. Before confinement measures came into effect mid-March, spatial predictors such as population density, as expected, were correlated to incidence. After the confinement came into effect, many such predictors no longer affected recorded incidence. We have assembled a rich database of demographic, socio-economic, and environmental indicators at the municipality level to identify spatial correlates of disease transmission. These are expected to differ pre- and through confinement, and to change further after confinement. We are also working...

Souad Rahmouni, Doctor

GIGA-Institute, ULiège - FNRS - Royal Academy of Sciences, Letters and Fine Arts of Belgium
" The main objective of our research program is the identification of human genetic factors impacting the COVID19 pandemic. Within the COVID-19 host genetics initiative (https://www.covid19hg.org/), we will establish a shared set of phenotypes to be combined with genomic data for standard GWAS and further meta-analysis. Field of expertise of our laboratory : genetics, genomics, bioinformatics, immune-response related diseases. In addition, the GIGA Institute is an interdisciplinary research institute from the ULiege devoted to academic excellence in the biomedical sciences to foster ground-breaking medical innovation. It comprises 583 members attached to six faculties (Medicine, Science, Veterinary Medicine, Engineering, Agbiotech, Psychology) that are organized in four disease-based (neuroscience, cancer, infection-inflammation-immunity, cardiovascular) and two method-based thematic units...

Stefan Constantinescu, Professor

UCLouvain - Royal Academy of Medicine of Belgium

Determination of Germ-Line Variations and Pathological Gene Expression that May Contribute to Immunopathology in COVID-19." The SARS-CoV-2 infection (1, 2), can be followed by a severe evolution with severe respiratory distress. We hypothesize that germline variants in genes involved in innate immunity, especially type I interferon induction and actions, predispose to delayed pathological response/cytokine storm. Our aims are to identify: i) such germ-line variants and ii) peripheral leukocyte gene expression that can predict unfavorable SARS-CoV2 infections. A group of SARS-CoV2 patients with unfavorable evolution, young and without co-morbidities (25) will be compared with an aged matched group of 25 SARS-CoV2 individuals with absence or a minimum of symptoms. Germ line DNA obtained from peripheral blood (PB) will be whole exome sequenced (WES) and analyzed with bioinformatics tools that are used for rare disease germline...

Stéphane CARLIER, Prof - Jean-Marie COLET, Prof - Fabrice JOURNE, Dr - Sven SAUSSEZ, Prof- Vincent RICHARD, Dr - Camélia ROSSI, Dr

UMONS and Ambroise-Paré Hospital Mons
" Predictive plasma signature of the clinical behavior of COVID-19 patients. The clinical presentation of COVID-19 infection varies from mild to asymptomatic to pneumonia, which can be complicated by severe respiratory failure and/or cardiovascular, renal, hepatic and cutaneous involvement. The understanding of such a polymorphism is very incomplete and the prognosis is difficult. Several tracks involving inflammatory reactions are currently favored to better explain this disease. In particular, the significant increase in plasma cytokines IL2, IL7, IL10, GSCF, IP10, MCP1, MIP1A and TNFα, known as "cytokine storm", seems to be significantly associated with the ARDS and multi-organ onsets. In this context, IL6 seems to play an important role and targeted treatments against this cytokine seem promising. Also, the infection of endothelial cells by the coronavirus causing endothelium inflammation have been suggested as one of the fundamental...

Sven Saussez, Pr. - Ornella Accaputo, Dr. - Claire Van Damme, Dr. - Catherine Debouck, Dr.- Evelyne Berlingin, Dr - Stéphane Carlier, Pr.

UMONS, CHU Ambroise Paré
" Following the observation of clinical cases of rashes at Ambroise Paré Hospital, the University of Mons and the team of dermatologists of the hospital initiated a research project to study various rashes that may be related to the current COVID-19 infection. These suspicious rashes are: acute urticaria, Gibert's pink pityriasis, frostbite, urticarial vasculitis, erythema multiforme and other atypical rashes. These rashes are known to accompany several viral infections, their current high number is of concern and we wish to evaluate whether COVID-19 infection could be the cause of them. "
Funding: internal funding
Contact: Pr. Sven Saussez, head of the laboratory of Human Anatomy and Experimental Oncology This email address is being protected from spambots. You need JavaScript enabled to view it.

Sven Saussez, Professor - Jérôme Lechien, Doctor

UMONS/ Epicura/ CHU Ambroise Paré/ Hôpital Foch
" In recent weeks, many European ear, nose and throat (ENT) specialists and infectious diseases specialists have observed that patients infected with coronavirus (COVID-19) had impaired sense of smell and taste. These symptoms of anosmia and dysgeusia were found in a large number of patients infected in Germany, France, Italy, Spain, England and the USA. Faced with the multiplication of declarations medical press, a group of ENT specialists from IFOS (the International Federation of ORL Societies), has developed a survey to investigate these sense of smell and taste disorders in patients infected with COVID-19 (infection being proven by PCR test). Pr. Sven Saussez and Dr. Jérôme Lechien from the University of Mons coordinated this study which was conducted by 33 ENT physicians and researchers in 12 European hospital "
Funding: CUR project submitted UMONS funding
Publication References: Olfactory and gustatory dysfunctions as a clinical...

Thomas Michiels, Professor

UCLouvain
" On the one hand, we are developing a safe, middle throughput seroneutralization assay to correlate standard serology to seroneutralization and to enable vaccine response analysis. On the other hand, we develop a basic research project on the identification of a promising drug target site in the RNA-dependent RNA polymerase of positive-stranded RNA viruses, conserved in SARS-CoV-2. During researches performed in the framework of an EOS program, we seredendipitously discovered a conserved region of viral RNA-dependent RNA-polymerases that has properties to be targetable by drugs. This site appears to be conserved in several viruses including SARS-CoV-2 and other important human pathogens. In collaboration with a swiss group working on coronaviruses and other partners, we plan to examine the impact of this polymerase target site on the replication of several viruses, its drugability and the reason for its conservation during evolution. "
Funding: - contribution to a small...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19